To investigate the impact of Nrf2 signaling in human ccRCC, Nrf2 gene mutations, the rs6721961 SNP, and Nrf2 protein expression were examined in patients with metastatic ccRCC. This evidence concerns the gene NFE2L2 and nonpapillary renal cell carcinoma.